Cargando…
High mortality from neo-adjuvant chemo-radiotherapy for rectal cancer needs to be evaluated against the alternative of adjuvant therapy
Autor principal: | Papagrigoriadis, S |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360526/ https://www.ncbi.nlm.nih.gov/pubmed/17016488 http://dx.doi.org/10.1038/sj.bjc.6603338 |
Ejemplares similares
-
Successful Downstaging of High Rectal and Recto-Sigmoid Cancer by Neo-Adjuvant Chemo-Radiotherapy
por: O’Neill, Brian, et al.
Publicado: (2008) -
Analysis of early postoperative complications in patients with resectable rectal cancer after neo-adjuvant chemo-radiotherapy
por: Grimaldi, Luciano, et al.
Publicado: (2013) -
H3K27me3 Immunohistochemical Loss Predicts Lower Response to Neo-Adjuvant Chemo-Radiotherapy in Rectal Carcinoma
por: Ammendola, Serena, et al.
Publicado: (2022) -
Neo-adjuvant chemo-radiation of rectal cancer with Volumetric Modulated Arc Therapy: summary of technical and dosimetric features and early clinical experience
por: Richetti, Antonella, et al.
Publicado: (2010) -
Short-course radiotherapy followed by neo-adjuvant chemotherapy in locally advanced rectal cancer – the RAPIDO trial
por: Nilsson, Per J, et al.
Publicado: (2013)